Komori
Governance4591RIBOMIC Inc.Pharmaceuticals

Notice Regarding Partial Amendments to the Articles of Incorporation

As matters to be submitted to the General Meeting of Shareholders, it was decided to increase the total number of authorized shares from 114,000,000 to 217,000,000 and change from a company with a Board of Corporate Auditors to a company with an Audit and Supervisory Committee. The amendments are scheduled to take effect at the conclusion of the General Meeting of Shareholders.

Worth reading
66In focus
Scored from 2 of 5 sections
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
103000000
Shares (increase in the total number of authorized shares)
Wording
Conditional
How definitive the wording is.

Governance structure

Scheduled to change from a company with a Board of Corporate Auditors to a company with an Audit and Supervisory Committee (scheduled to take effect at the conclusion of the Annual General Meeting of Shareholders scheduled for 23 June 2026)
Number of directorsUp to 5 directors, excluding directors who are Audit and Supervisory Committee members, and up to 4 directors who are Audit and Supervisory Committee members. The number of outside directors is not disclosed.
Committee1
Audit and Supervisory Committee. The proportion of outside committee members is not disclosed.
Changes this time

The total number of authorized shares is scheduled to change from 114,000,000 to 217,000,000. The Company is scheduled to change from a company with a Board of Corporate Auditors to a company with an Audit and Supervisory Committee. Provisions concerning Audit and Supervisory Committee members and the Audit and Supervisory Committee, as well as provisions concerning the delegation of decisions on important business execution, will be newly established, while provisions concerning corporate auditors and the Board of Corporate Auditors will be deleted.

Governance structure
ItemDetails
Corporate Governance StructureScheduled to change from a company with a Board of Corporate Auditors to a company with an Audit and Supervisory Committee (scheduled to take effect at the conclusion of the Annual General Meeting of Shareholders scheduled for 23 June 2026)
Number of directorsUp to 5 directors, excluding directors who are Audit and Supervisory Committee members, and up to 4 directors who are Audit and Supervisory Committee members. The number of outside directors is not disclosed.
CommitteeAudit and Supervisory Committee. The proportion of outside committee members is not disclosed.
Changes this timeThe total number of authorized shares is scheduled to change from 114,000,000 to 217,000,000. The Company is scheduled to change from a company with a Board of Corporate Auditors to a company with an Audit and Supervisory Committee. Provisions concerning Audit and Supervisory Committee members and the Audit and Supervisory Committee, as well as provisions concerning the delegation of decisions on important business execution, will be newly established, while provisions concerning corporate auditors and the Board of Corporate Auditors will be deleted.
Items this document does not state (4)
Number of independent officersPolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To broaden the Company's options for raising funds and enable flexible financing in preparation for future business expansion. In addition, to further enhance corporate value by strengthening the Board of Directors' supervisory function, accelerating decision-making through the delegation of authority over execution, and invigorating the Board of Directors.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding Partial Amendments to the Articles of Incorporation | RIBOMIC Inc. (4591) timely disclosure | Komori